CD8A and severe acute respiratory syndrome: In consideration of the emergence of nAb escape mutant and clinical observations in SARS patients who showed a decrease of CD8+ memory T cells [48], it is desirable to develop a SARS vaccine which can induce both humoral and cellular immune responses.